Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 27 Lymphoma, Non-Hodgkin 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma, Mantle-Cell 23 Lymphoma, Follicular 17 Lymphoma, Large B-Cell, Diffuse 15 Multiple Myeloma 14 Recurrence 13 Hodgkin Disease 12 Lymphoma, B-Cell, Marginal Zone 7 Leukemia 7 Waldenstrom Macroglobulinemia 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms, Plasma Cell 4 Neoplasms 4 Leukemia, B-Cell 4 Hematologic Neoplasms 4 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, T-Cell 3 Lymphoma, B-Cell 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphoid 3 Small Cell Lung Carcinoma 2 Leukemia, Biphenotypic, Acute 2 Burkitt Lymphoma 2 Sezary Syndrome 1 Sarcoma 1 Renal Insufficiency, Chronic 1

Interventions

Trastuzumab 304 Paclitaxel 258 Cyclophosphamide 251 Docetaxel 238 Capecitabine 176 Letrozole 163 Carboplatin 163 Fulvestrant 145 Doxorubicin 145 Bevacizumab 121 Anastrozole 106 Tamoxifen 102 exemestane 94 Vinorelbine 91 Epirubicin 90 pertuzumab 89 Gemcitabine 84 Lapatinib 80 Albumin-Bound Paclitaxel 74 Radiotherapy 71 pembrolizumab 70 palbociclib 64 130-nm albumin-bound paclitaxel 58 eribulin 56 Cisplatin 55 Everolimus 49 pyrotinib 45 Taxes 44 Goserelin 43 Neoadjuvant Therapy 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Neoplasms × Bendamustine Hydrochloride × Clear all

NCT01891227 2018-11-07

MBC-6

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡